(Q73920236)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10865219%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Cyclical etidronate versus sodium fluoride in established postmenopausal osteoporosis: a randomized 3 year trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10865219%20AND%20SRC:MED&resulttype=core&format=json

postmenopausal osteoporosis

7 November 2019

main subject

1 reference

N Guañabens

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10865219%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J Farrerons

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10865219%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

L Perez-Edo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10865219%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A Monegal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10865219%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A Renau

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10865219%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J Carbonell

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10865219%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Roca

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10865219%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Torra

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10865219%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Pavesi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10865219%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 July 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10865219%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10865219%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10865219%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10865219%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

123-128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10865219%20AND%20SRC:MED&resulttype=core&format=json

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900303-3

7 January 2021

Sodium fluoride treatment is a major protector against vertebral and nonvertebral fractures when compared with other common treatments of osteoporosis: a longitudinal, observational study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900303-3

7 January 2021

Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900303-3

7 January 2021

Fluoride and osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900303-3

7 January 2021

Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900303-3

7 January 2021

Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900303-3

7 January 2021

Cyclic etidronate: has the rose lost its bloom?

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900303-3

7 January 2021

Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900303-3

7 January 2021

Cyclical etidronate in the treatment of postmenopausal osteoporosis: efficacy and safety after seven years of treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900303-3

7 January 2021

Treatment of the vertebral crush fracture syndrome with enteric-coated sodium fluoride tablets and calcium supplements

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900303-3

7 January 2021

Treatment of postmenopausal osteoporosis with slow-release sodium fluoride. Final report of a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900303-3

7 January 2021

Comparison of nonrandomized trials with slow-release sodium fluoride with a randomized placebo-controlled trial in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900303-3

7 January 2021

The role of bisphosphonates in the prevention and treatment of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900303-3

7 January 2021

The effect of sodium monofluorophosphate plus calcium on vertebral fracture rate in postmenopausal women with moderate osteoporosis. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900303-3

7 January 2021

Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900303-3

7 January 2021

Clinical trial of fluoride therapy in postmenopausal osteoporotic women: extended observations and additional analysis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900303-3

7 January 2021

Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900303-3

7 January 2021

Intermittent cyclical etidronate treatment of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900303-3

7 January 2021

10.1016/S8756-3282(00)00303-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10865219%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference